Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 17
178
Views
0
CrossRef citations to date
0
Altmetric
Short communications

Antileshimania, anti-Trypanosoma cruzi and antimicrobial activities of scandenin and 4'-O-methylderrone from Deguelia costata

, , , , ORCID Icon, , , , , , & show all
Pages 2951-2956 | Received 11 May 2022, Accepted 16 Oct 2022, Published online: 29 Oct 2022
 

Abstract

Scandenin and 4'-O-methylderrone were isolated from the ethanol extract of the roots and dichloromethane extract of the leaves of Deguelia costata (Benth.) A.M.G. Azevedo & R.A. Camargo, respectively. These compounds and their extracts had their antiprotozoal, antibacterial, antifungal, and cytotoxic activities tested. All samples were active for amastigotes of the T. cruzi, with EC50 values varying from 34.5 to 9.8 µg mL−1. The 4'-O-methylderrone and scandenin showed better leishmanicidal action against the promastigote of L. amazonensis, with EC50 of 43.3 and 45.9 µg mL−1, respectively, when compared to their extracts. All extracts and scandenin showed activities against Staphylococcus sp, Bacillus sp, and Candida sp. The compounds did not show cytotoxicity on rat macrophages. As confirmed by spectroscopic analyses, the extracts are rich in phenolics, mainly isoflavonoids. The study of D. costata is a promising strategy for discovering isoflavones and 4-hydroxy-3-phenylcoumarins with antiprotozoal, antibacterial, and antifungal activities.

Graphical Abstract

Acknowledgements

The authors would like to thank the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado da Bahia, Departamento de Ciências Exatas e da Terra I -UNEB and Laboratório Baiano de Ressonância Magnética Nuclear da Bahia - UFBA.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

CAPES;Funda??o de Amparo ? Pesquisa do Estado da Bahia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.